Ajinomoto To Increase Pharmaceutical Business To ¥100 Billion In 2015
This article was originally published in PharmAsia News
Executive Summary
Ajinomoto Jan. 29 announced a business plan to increase its pharmaceutical business from ¥15 billion in 2009 to ¥100 billion in 2015